1. Market Research
  2. > Pharmaceutical Market Trends
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2016

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2016

  • April 2017
  • 111 pages
  • ID: 1105509
In this report:
In addition, After the establishment of the JV, HEC is expected to enter into an equity transfer agreement with TaiGen Biopharma to acquire the ##% equity interests in the JV held by TaiGen Biopharma at a consideration of USD## million or USD## million subject to the terms and conditions set out in the shareholders' agreement.
In deal values, capital raising segment amounted to USD##.## billion in Q## 2016, constituting ##% of the total deal value, followed by M&A segment with ##%.


Table of Contents

Search Inside

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2016


GlobalData's "Alliances, Licensing, Investments and M&A Deals and Forecasts in Pharmaceuticals - Q4 2016", report is an vitally source of data and trend analysis on alliances, licensing, M&A and financings in the pharmaceuticals industry. The study offers exhaustive information on partnership and licensing transactions, M&As, equity/corporate debt offerings, private equity investment, and venture capital financing registered in the pharmaceuticals industry in Q4 2016. The analysis portrays comprehensive comparative data on the number of transactions and their value in the final five quarters, subdivided by business deal types, different therapy areas, and geographies. On top of, The study offers data on the most important financial advisory firms in the pharmaceuticals industry.

Info exhibited in this industry report is derived from GlobalData's proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

The pharmaceutical and healthcare industry reported a decrease in the number of business deals and deal values in Q4 2016 with 986 deals worth USD81.7 billion, as compared 1,194 worth USD85.9 billion in Q4 2015. On a quarter-on-quarter basis, the number of accords and deal values decreased in Q4 2016, when compared to 1,009 deals worth USD112.6 billion in Q3 2016. The pharmaceutical and healthcare industry reported a decrease in upfront payments in licensing agreements with USD1 billion in Q4 2016, as compared USD1.6 billion in Q4 2015. On a quarter-on-quarter basis, the upfront payments reported an increase in Q4 2016, when compared to USD589.2m in Q3 2016. Transactions in oncology therapeutics market registered an increase with 339 deals in Q4 2016, compared to 330 deals in Q3 2016. North America (NA) registered a decrease in the number of transactions with 630 deals in Q4 2016, compared to 690 deals in Q3 2016.


- Analysis of the market trends for the pharmaceutical industry in the overall arena.

- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.

- Analysis of partnerships, licensing, M&As, equity/corporate debt offerings, private equity investment, and venture financing deals in the pharmaceutical industry.

- Analysis of therapy areas which are very active in terms of venture capital financing, alliances, licensing agreements, equity/corporate debt offerings, and M&As.

- Analysis of deals established on distinct payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.

- Analysis of partnership and licensing deals established on clinical stage of development of products.



of the pharmaceutical deals globally in the five quarters.

- Info on the best deals happened in the pharmaceutical industry.

- Geographies covered include - North America continent, Europe (EU), Asia Pacific (APAC), South & Central America, and the Middle East (ME) & African continent.

- League tables of financial advisors in M&As and equity/corporate debt offerings. This includes main advisors including Morgan Stanley, Credit Suisse, and Goldman Sachs.

Great reasons to purchase

- Enhance your decision making capability in a more quick and time sensitive manner.

- Find out the main deal performing segments for investments in your industry.

- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.

- Identify companies that are aggressively looking to raise capital in the industry

- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.

- Identify the top venture capitalists, who are financing the pharmaceutical and biotech companies.

- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.

- Do transactions with an understanding of how competitors are financed, and the mergers and alliances that have shaped the pharmaceutical industry.

- Identify growth segments and alternatives in each region within the industry.

- Look for main financial advisors where you are planning to raise capital from the sector or for acquisitions within the industry.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Drug Discovery Services Market by Process, Type, Drug Type, Therapeutic Areas - Forecast to 2022

Drug Discovery Services Market: Forecast until 2022

  • $ 5650
  • Industry report
  • October 2017
  • by MarketsandMarkets

“The drug discovery services market projected to grow at a CAGR of 11.6%.”The drug discovery services market was valued at USD 8.32 billion in 2017 and expected to grow at a CAGR of 11.6% to reach ...

Drug Discovery Informatics Market by Function, Solution, End User - Global Forecast to 2022

Drug Discovery Informatics Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • December 2017
  • by MarketsandMarkets

The global drug discovery informatics market is projected to grow at a CAGR of 11.2%.The global drug discovery informatics market is expected to reach USD 2.84 billion in 2022 from USD 1.67 billion in ...

Global Pharmaceutical Filtration Market 2017-2021

Pharmaceutical Filtration Sector: Worldwide Forecast until 2021

  • $ 3500
  • Industry report
  • October 2017
  • by Infiniti Research Limited

About Pharmaceutical FiltrationFiltration is a method used to separate or collect a desired solid from a solution or to remove solid impurities from a liquid. Pharmaceutical filtration refers to the process ...

Canada: Pharmaceuticals market $ 657 December 2017

Italy: Pharmaceuticals report $ 657 December 2017

France: Pharmaceuticals market $ 657 November 2017


Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.